Whalegun
Home

Sujal Shah, CEO: CymaBay Therapeutics CBAY Sell · Filed 23/11/14

Trade details

Type
Insider sale
Amount
$699,287.12
Shares · price
44,008 sh · $15.89 a share
Held after
171,301 sh
Stock
CymaBay Therapeutics CBAY
Person
Sujal ShahCEO
Trade date
23/11/13
Filed
23/11/14
Days to filing
1 days

Sold 20.4% of holdings

Share of holding sold
20.4%

CymaBay Therapeutics trades, last 26 weeks

What else happened in CymaBay Therapeutics around then

Filed or reported within 30 days of the trade day · 23/10/14~23/12/13

Sujal Shah's recent trades

  • Sujal Shah

    Sell10b5-1 planCymaBay Therapeutics

    $1.3M

    Filed 23/12/11

  • Sujal Shah

    Sell10b5-1 planCymaBay Therapeutics

    $18.5K

    Filed 23/12/11

  • Sujal Shah

    Sell10b5-1 planCymaBay Therapeutics

    $331.4K

    Filed 23/11/14

  • Sujal Shah

    Sell10b5-1 planCymaBay Therapeutics

    $921K

    Filed 23/10/10

Sujal Shah, CEO — sold $699.3K of CymaBay Therapeutics CBAY · 20.4% of holdings · 10b5-1 plan | Whalegun